Akebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of Directors
"We are thrilled to welcome Dr.
"I share Akebia's passion and commitment to advancing care of patients with kidney disease," said
"We would like to extend our sincere appreciation to Jodie for her service, insights, and contributions on Akebia's Board, and additionally for her work as interim CEO of Keryx in completing the transaction that created today's Akebia," stated Adams.
View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-appoints-myles-wolf-md-mmsc-chief-of-nephrology-and-professor-at-duke-university-school-of-medicine-to-board-of-directors-301036600.html